- £234.14m
- £108.59m
- $432.70m
- 32
- 77
- 38
- 44
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 355 | 377 | 160 | 335 | 433 |
Cost of Revenue | |||||
Gross Profit | 192 | 182 | -26.3 | 116 | 233 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 610 | 245 | 524 | 612 | 414 |
Operating Profit | -255 | 132 | -365 | -277 | 18.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -283 | 105 | -417 | -308 | -7.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -284 | 104 | -417 | -308 | -7.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -284 | 104 | -417 | -308 | -7.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -284 | 104 | -417 | -308 | -7.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.029 | 0.475 | -0.842 | -0.166 | 0.443 |
Dividends per Share |